The safety and efficacy of leflunomide (LEF) in combination with infliximab (INF) in rheumatoid arthritis (RA).

被引：0
|
作者：
Hansen, KE
Cush, J
Singhal, A
Cooley, DA
Cohen, S
Patel, SR
Genovese, M
Sundaramurthy, S
Schiff, M
机构：
来源：
ARTHRITIS AND RHEUMATISM | 2001年 / 44卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
188
引用
收藏
页码：S84 / S84
页数：1
相关论文
共 50 条
  • [1] The safety and efficacy of leflunomide in combination with infliximab in rheumatoid arthritis
    Hansen, KE
    Cush, J
    Singhal, A
    Cooley, DA
    Cohen, S
    Patel, SR
    Genovese, M
    Sundaramurthy, S
    Schiff, M
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2004, 51 (02): : 228 - 232
  • [2] Efficacy and safety of Remicade® (infliximab) plus Arava™ (Leflunomide) in rheumatoid arthritis (RA).
    Patel, S
    Bergen, W
    Kraemer, A
    Keenan, GF
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S84 - S84
  • [3] Safety and efficacy of leflunomide and infliximab versus methotrexate and infliximab combination therapy in rheumatoid arthritis
    Ibáñez, TC
    Tayel, MY
    Criado, AB
    Sanz, AH
    Mola, E
    [J]. RHEUMATOLOGY, 2005, 44 (11) : 1467 - 1468
  • [4] Safety of leflunomide plus infliximab combination therapy in rheumatoid arthritis
    Godinho, F
    Godfrin, B
    El Mahou, S
    Navaux, F
    Zabraniecki, L
    Cantagrel, A
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2004, 22 (03) : 328 - 330
  • [5] Combination treatment with infliximab and methotrexate or leflunomide in active rheumatoid arthritis. Safety and efficacy
    Athanassiou, P
    Kostoglou-Athanassiou, I
    Koutsogeorgopoulou, L
    Galanaki, C
    Kordalis, A
    Konstantopoulou, R
    Sarlanis, T
    Vezyroglou, G
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 464 - 464
  • [6] Combination of leflunomide and infliximab in rheumatoid arthritis
    Sakellariou, GT
    Kakavouli, G
    Spyropoulou, E
    Tryfonidis, P
    Chatzigiannis, I
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 469 - 469
  • [7] Efficacy of and predisposing factors for response to leflunomide (LEF) in patients with rheumatoid arthritis (RA)
    Dougados, M
    Antoine, C
    Brin, S
    Emery, P
    Lemmel, EM
    de la Serna, AR
    Zerbini, CAF
    Van Riel, P
    [J]. JOURNAL OF RHEUMATOLOGY, 2001, 28 : 105 - 105
  • [8] Safety and efficacy of the combination of leflunomide and etanercept in rheumatoid arthritis
    Fiocco, U.
    Vezzu, M.
    Sfriso, P.
    Cozzi, L.
    Checchetto, C.
    Ciprian, L.
    Botsios, C.
    Todesco, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 190 - 191
  • [9] Five year follow-up: Efficacy and safety of leflunomide (LEF) in patients with active rheumatoid arthritis (RA).
    Kalden, J
    Schattenkirchner, M
    Sorensen, H
    Emery, P
    Deighton, C
    Rozman, B
    Breedveld, F
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S173 - S173
  • [10] EFFICACY AND SAFETY OF LEFLUNOMIDE IN THE TREATMENT OF PATIENTS WITH RHEUMATOID-ARTHRITIS (RA)
    DOMLJAN, Z
    POPOVIC, M
    MIADENOVIC, V
    ROZMAN, B
    MIHAJLOVIC, D
    JAJIC, I
    ZIVKOVIC, M
    STRAND, V
    LOWFRIEDRICH, I
    OED, C
    MUSIKIC, P
    SEIFERT, H
    [J]. ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S56 - S56
12345